PT Kedoya Adyaraya Tbk (IDX:RSGK)

Ligand Pharmaceuticals Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	38,293	54,397	57,424	173,741	138,778	32,156
Short-Term Investments	-	4,500	21,500	12,000	110,000	23,000
Cash & Short-Term Investments	38,293	58,897	78,924	185,741	248,778	55,156
Cash Growth	-62.20%	-25.37%	-57.51%	-25.34%	351.04%	46.85%
Accounts Receivable	55,394	49,676	47,332	30,546	35,528	31,049
Other Receivables	1,394	1,289	1,805	952.82	1,735	21,963
Receivables	56,788	50,964	49,137	31,499	37,263	53,011
Inventory	13,846	15,531	14,587	12,001	13,928	12,875
Prepaid Expenses	13.81	5.73	86.1	-	206.91	249.47
Other Current Assets	5,141	1,838	953.1	396.03	210.02	194.9
Total Current Assets	114,082	127,236	143,687	229,638	300,386	121,487
Property, Plant & Equipment	675,926	682,881	650,484	646,799	630,137	588,591
Long-Term Investments	-	-	-	-	-	7,201
Long-Term Deferred Tax Assets	17,132	16,942	18,613	11,715	13,162	16,480
Other Long-Term Assets	121,014	60,568	16,013	5,536	1,769	18,984
Total Assets	928,153	887,628	828,796	893,688	945,454	752,743
Accounts Payable	23,270	26,877	18,636	17,017	16,937	24,964
Accrued Expenses	28,001	35,872	32,865	35,789	29,489	17,338
Short-Term Debt	31,000	-	-	-	9,058	52,204
Current Portion of Long-Term Debt	-	-	-	-	6,436	14,109
Current Portion of Leases	-	-	-	575.39	2,118	2,136
Current Income Taxes Payable	3,209	5,269	7,360	10,603	16,299	6,478
Current Unearned Revenue	2,482	742.38	2,048	2,872	1,517	2,624
Other Current Liabilities	27.77	894.68	1,302	2,150	1,323	4,927
Total Current Liabilities	87,989	69,654	62,211	69,006	83,176	124,780
Long-Term Debt	-	-	-	-	11,964	130,572
Long-Term Leases	-	-	-	-	575.39	2,694
Total Liabilities	110,400	89,167	77,634	78,154	101,235	265,009
Common Stock	185,935	185,935	185,935	185,935	185,935	148,747
Additional Paid-In Capital	280,922	280,922	280,922	280,922	280,922	3,072
Retained Earnings	97,471	78,221	48,755	112,815	166,587	110,360
Comprehensive Income & Other	252,664	252,591	234,710	234,925	210,450	220,754
Total Common Equity	816,992	797,669	750,323	814,597	843,895	482,933
Minority Interest	760.71	791.69	839.96	936.87	324.62	4,800
Shareholders' Equity	817,753	798,461	751,162	815,534	844,219	487,734
Total Liabilities & Equity	928,153	887,628	828,796	893,688	945,454	752,743
Total Debt	31,000	-	-	575.39	30,151	201,714
Net Cash (Debt)	7,293	58,897	78,924	185,166	218,627	-146,558
Net Cash Growth	-92.80%	-25.37%	-57.38%	-15.30%	-	-
Net Cash Per Share	7.84	63.35	84.89	199.17	440.88	-197.06
Filing Date Shares Outstanding	929.68	929.68	929.68	929.68	929.68	743.74
Total Common Shares Outstanding	929.68	929.68	929.68	929.68	929.68	743.74
Working Capital	26,092	57,582	81,476	160,632	217,210	-3,294
Book Value Per Share	878.79	858.01	807.08	876.22	907.73	649.34
Tangible Book Value	816,992	797,669	750,323	814,597	843,895	482,933
Tangible Book Value Per Share	878.79	858.01	807.08	876.22	907.73	649.34
Land	446,080	446,080	430,094	430,094	402,841	345,400
Buildings	281,336	275,402	264,833	263,206	263,194	263,024
Machinery	292,290	290,767	258,136	225,311	209,023	197,940
Construction In Progress	-	-	154	154	154	-

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.